Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q9H9E3 25839 COG4 Bladder urothelial carcinoma Phosphorylation N S10 Q9H9E3 25839 COG4 Skin cutaneous melanoma Phosphorylation N S10 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Phosphorylation N S21 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K77 Q9H9E3 25839 COG4 Skin cutaneous melanoma Ubiquitination N K77 Q9H9E3 25839 COG4 Esophageal carcinoma Ubiquitination N K123 Q9H9E3 25839 COG4 Skin cutaneous melanoma Ubiquitination N K123 Q9H9E3 25839 COG4 Kidney renal papillary cell carcinoma Ubiquitination N K170 Q9H9E3 25839 COG4 Stomach adenocarcinoma Ubiquitination N K170 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K180 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Phosphorylation C S183 Q9H9E3 25839 COG4 Colon adenocarcinoma Ubiquitination N K190 Q9H9E3 25839 COG4 Colon adenocarcinoma Ubiquitination N K200 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K200 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Ubiquitination N K238 Q9H9E3 25839 COG4 Pancreatic adenocarcinoma Ubiquitination N K238 Q9H9E3 25839 COG4 Pancreatic adenocarcinoma Ubiquitination N K245 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Ubiquitination N K324 Q9H9E3 25839 COG4 Head and neck squamous cell carcinoma Ubiquitination N K324 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Ubiquitination N K327 Q9H9E3 25839 COG4 Head and neck squamous cell carcinoma Ubiquitination N K327 Q9H9E3 25839 COG4 Breast invasive carcinoma Ubiquitination N K350 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Phosphorylation N S382 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Phosphorylation N S383 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K397 Q9H9E3 25839 COG4 Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K447 Q9H9E3 25839 COG4 Rectum adenocarcinoma Acetylation N K447 Q9H9E3 25839 COG4 Saul-Wilson syndrome Phosphorylation N S515 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Phosphorylation N S519 Q9H9E3 25839 COG4 Failure to thrive Phosphorylation N S519 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Phosphorylation N S527 Q9H9E3 25839 COG4 Head and neck squamous cell carcinoma Phosphorylation N S527 Q9H9E3 25839 COG4 Head and neck squamous cell carcinoma Ubiquitination N K536 Q9H9E3 25839 COG4 Thyroid carcinoma Ubiquitination N K536 Q9H9E3 25839 COG4 Stomach adenocarcinoma Ubiquitination N K575 Q9H9E3 25839 COG4 Bladder urothelial carcinoma Ubiquitination N K589 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K589 Q9H9E3 25839 COG4 Congenital disorder of glycosylation Ubiquitination N K697 Q9H9E3 25839 COG4 Stomach adenocarcinoma Ubiquitination N K697 Q9H9E3 25839 COG4 Uterine corpus endometrial carcinoma Ubiquitination N K710 Q9H9E3 25839 COG4 Skin cutaneous melanoma Phosphorylation N Y718 Q9H9E3 25839 COG4 Uterine corpus endometrial carcinoma Phosphorylation N Y718